Wells Fargo’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$634K Buy
17,440
+171
+1% +$6.22K ﹤0.01% 3624
2025
Q1
$625K Sell
17,269
-13,102
-43% -$474K ﹤0.01% 3524
2024
Q4
$1.28M Sell
30,371
-2,886
-9% -$121K ﹤0.01% 3111
2024
Q3
$1.85M Buy
33,257
+4,398
+15% +$244K ﹤0.01% 2806
2024
Q2
$1.19M Sell
28,859
-2,549
-8% -$105K ﹤0.01% 3078
2024
Q1
$1.47M Sell
31,408
-10,348
-25% -$483K ﹤0.01% 2898
2023
Q4
$2M Sell
41,756
-19,217
-32% -$919K ﹤0.01% 2640
2023
Q3
$2.17M Buy
60,973
+19,393
+47% +$691K ﹤0.01% 2559
2023
Q2
$1.92M Sell
41,580
-74
-0.2% -$3.41K ﹤0.01% 2803
2023
Q1
$1.67M Buy
41,654
+31,124
+296% +$1.25M ﹤0.01% 2827
2022
Q4
$488K Buy
10,530
+2,482
+31% +$115K ﹤0.01% 3431
2022
Q3
$333K Sell
8,048
-3,297
-29% -$136K ﹤0.01% 3682
2022
Q2
$677K Buy
11,345
+6,061
+115% +$362K ﹤0.01% 3340
2022
Q1
$383K Buy
5,284
+1,932
+58% +$140K ﹤0.01% 4314
2021
Q4
$282K Sell
3,352
-2,196
-40% -$185K ﹤0.01% 4721
2021
Q3
$500K Sell
5,548
-51,885
-90% -$4.68M ﹤0.01% 4400
2021
Q2
$5.48M Sell
57,433
-16,433
-22% -$1.57M ﹤0.01% 2679
2021
Q1
$8.41M Sell
73,866
-10,777
-13% -$1.23M ﹤0.01% 2245
2020
Q4
$11.7M Buy
84,643
+43,404
+105% +$6.01M ﹤0.01% 1953
2020
Q3
$3.39M Sell
41,239
-17,775
-30% -$1.46M ﹤0.01% 2826
2020
Q2
$4.62M Buy
59,014
+24,075
+69% +$1.88M ﹤0.01% 2502
2020
Q1
$1.55M Sell
34,939
-16,015
-31% -$711K ﹤0.01% 3150
2019
Q4
$2.18M Buy
50,954
+12,348
+32% +$528K ﹤0.01% 3252
2019
Q3
$1.65M Sell
38,606
-41,083
-52% -$1.76M ﹤0.01% 3442
2019
Q2
$5.06M Sell
79,689
-1,597
-2% -$101K ﹤0.01% 2548
2019
Q1
$5.64M Buy
81,286
+55,405
+214% +$3.84M ﹤0.01% 2436
2018
Q4
$1.13M Buy
25,881
+2,139
+9% +$93K ﹤0.01% 3680
2018
Q3
$1.81M Buy
23,742
+1,194
+5% +$91.1K ﹤0.01% 3452
2018
Q2
$1.73M Sell
22,548
-1,652
-7% -$127K ﹤0.01% 3523
2018
Q1
$1.23M Buy
24,200
+1,149
+5% +$58.6K ﹤0.01% 3695
2017
Q4
$1.07M Sell
23,051
-23,793
-51% -$1.1M ﹤0.01% 3821
2017
Q3
$2.49M Sell
46,844
-213,864
-82% -$11.4M ﹤0.01% 3098
2017
Q2
$16.2M Sell
260,708
-301,682
-54% -$18.7M 0.01% 1525
2017
Q1
$38.1M Sell
562,390
-202,304
-26% -$13.7M 0.01% 1001
2016
Q4
$53.8M Buy
764,694
+28,887
+4% +$2.03M 0.02% 798
2016
Q3
$52.2M Sell
735,807
-612,348
-45% -$43.4M 0.02% 764
2016
Q2
$65.9M Sell
1,348,155
-380,807
-22% -$18.6M 0.03% 627
2016
Q1
$109M Sell
1,728,962
-45,774
-3% -$2.9M 0.04% 440
2015
Q4
$199M Buy
1,774,736
+219,746
+14% +$24.7M 0.08% 285
2015
Q3
$150M Buy
1,554,990
+726,445
+88% +$70M 0.06% 335
2015
Q2
$84.8M Buy
828,545
+817,444
+7,364% +$83.7M 0.03% 572
2015
Q1
$690K Buy
11,101
+8,895
+403% +$553K ﹤0.01% 3686
2014
Q4
$96K Buy
2,206
+1,585
+255% +$69K ﹤0.01% 4598
2014
Q3
$35K Sell
621
-213
-26% -$12K ﹤0.01% 4927
2014
Q2
$37K Buy
834
+408
+96% +$18.1K ﹤0.01% 4954
2014
Q1
$21K Buy
+426
New +$21K ﹤0.01% 5072